CAMP Q4 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$97M+9.2% YoY

Gross Profit

$37M38.2% margin

Operating Income

-$4M-4.1% margin

Net Income

-$7M-7.7% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$3M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$562M

Total Liabilities

$372M

Stockholders' Equity

$191M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$97M	$88M	+9.2%
Gross Profit	$37M	$36M	+1.4%
Operating Income	-$4M	$599,000	-767.3%
Net Income	-$7M	-$522,000	-1320.5%

Revenue Segments

Product

$63M65%

Application Subscriptions And Related Products And Service

$33M35%

Geographic Segments

UNITED STATES

$70M72%

E M E A

$15M15%

All Other

$5M6%

Asia Pacific

$3M3%

CANADA

$2M2%

Latin America

$1M1%